US equities
|
INTC
$64.77
▼-29.65%
AMZN
$238.69
▼-2.09%
MU
$881.46
▼-5.65%
NVDA
$205.47
▼-3.83%
SNDK
$1,168.92
▼-12.11%
GOOGL
$281.98
▼-0.65%
SPCX
$138.31
▼-3.88%
TSLA
$400.12
▼-0.79%
INTC
$64.77
▼-29.65%
AMZN
$238.69
▼-2.09%
MU
$881.46
▼-5.65%
NVDA
$205.47
▼-3.83%
SNDK
$1,168.92
▼-12.11%
GOOGL
$281.98
▼-0.65%
SPCX
$138.31
▼-3.88%
TSLA
$400.12
▼-0.79%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Tools
My watchlist
My portfolio
Recent quotes
Articles published by AccuStem Sciences, Inc
AccuStem Sciences, Inc. Announces Chairman Purchase of Shares
January 03, 2025
From
AccuStem Sciences, Inc
Via
GlobeNewswire
Tickers
ACUT
AccuStem Sciences, Inc. and EmeritusDX Announce Joint Product Development Agreement and Strategic Partnership
July 17, 2023
From
AccuStem Sciences, Inc
Via
GlobeNewswire
Tickers
ACUT
AccuStem Sciences, Inc. Extends and Broadens Partnership with Instituto Europeo di Oncologia (IEO) Enabling its Strategic Approach to Address Unanswered Clinical Questions in Early Stage Breast Cancer
July 11, 2023
From
AccuStem Sciences, Inc
Via
GlobeNewswire
Tickers
ACUT